Loading…
Allergan, a medical device manufacturer, received an FDA Warning Letter on May 14, 2020. Based on the limited metadata available, the specific regulatory violations cannot be determined as the subject line is not provided. The letter was issued regarding medical devices, though the specific issuing office and violation count are unknown, limiting full assessment of the regulatory scope and nature of the compliance issues.